DK509287A - Analysemetode og diagnosesaet til undersoegelse af unormal lipidmetabolisme - Google Patents

Analysemetode og diagnosesaet til undersoegelse af unormal lipidmetabolisme

Info

Publication number
DK509287A
DK509287A DK509287A DK509287A DK509287A DK 509287 A DK509287 A DK 509287A DK 509287 A DK509287 A DK 509287A DK 509287 A DK509287 A DK 509287A DK 509287 A DK509287 A DK 509287A
Authority
DK
Denmark
Prior art keywords
investigation
diagnosis
analysis
lipid metabolism
abnormal lipid
Prior art date
Application number
DK509287A
Other languages
English (en)
Other versions
DK509287D0 (da
DK173724B1 (da
Inventor
Richard S Smith
Doreen M Hogle
Linda K Curtiss
Joseph L Witztum
Steven Young
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK509287D0 publication Critical patent/DK509287D0/da
Publication of DK509287A publication Critical patent/DK509287A/da
Application granted granted Critical
Publication of DK173724B1 publication Critical patent/DK173724B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Arrangements For Transmission Of Measured Signals (AREA)
DK198705092A 1986-09-29 1987-09-28 Analysemetode og diagnosesæt til undersøgelse af unormal lipidmetabolisme DK173724B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/913,140 US4828986A (en) 1986-09-29 1986-09-29 Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
US91314086 1986-09-29

Publications (3)

Publication Number Publication Date
DK509287D0 DK509287D0 (da) 1987-09-28
DK509287A true DK509287A (da) 1988-03-30
DK173724B1 DK173724B1 (da) 2001-07-30

Family

ID=25432962

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198705092A DK173724B1 (da) 1986-09-29 1987-09-28 Analysemetode og diagnosesæt til undersøgelse af unormal lipidmetabolisme

Country Status (17)

Country Link
US (1) US4828986A (da)
EP (1) EP0262854B1 (da)
JP (1) JP2656774B2 (da)
AT (1) ATE85435T1 (da)
AU (1) AU611096B2 (da)
CA (1) CA1285869C (da)
DE (1) DE3783991T2 (da)
DK (1) DK173724B1 (da)
ES (1) ES2053555T3 (da)
FI (1) FI89214C (da)
GR (1) GR3008027T3 (da)
IE (1) IE60119B1 (da)
IL (1) IL83938A (da)
NO (1) NO173902C (da)
NZ (1) NZ221941A (da)
PT (1) PT85827B (da)
ZA (1) ZA876970B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751182T2 (de) * 1986-08-06 1995-10-26 Scripps Clinic Res Monoklonale Antikörper, B-spezifisch für Apolipoprotein, die von zwei Hybridomen erzeugt werden.
DE3734015A1 (de) * 1987-10-08 1989-04-20 Behringwerke Ag Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b
AU621575B2 (en) * 1987-11-02 1992-03-19 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
US5183738A (en) * 1988-09-29 1993-02-02 Japan Immuno Research Laboratories Co., Ltd. Kit for the detection of denatured lipoproteins
US5179008A (en) * 1989-02-09 1993-01-12 Wisconsin Alumni Research Foundation Hybridoma and monoclonal antibody to FHAP
US5168045A (en) * 1989-08-18 1992-12-01 The Scripps Research Institute Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
AU662885B2 (en) * 1990-06-07 1995-09-21 Scripps Research Institute, The APO AI polypeptides, antibodies, and immunoassays
WO1992009893A1 (en) * 1990-11-29 1992-06-11 Carbaugh John E DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN(a)
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
AU667462B2 (en) * 1990-11-30 1996-03-28 Monoclonetics International Incorporated Methods for the diagnosis of chronic lower back and cervical pain
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
WO1994007146A1 (en) * 1992-09-24 1994-03-31 Perseptive Biosystems, Inc. Quantitative measurement of ldl
US6107045A (en) * 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
US5994061A (en) * 1995-09-29 1999-11-30 Queen's University At Kingston DNA constructs and methods for screening for increased expression of human apo AI gene
US5741647A (en) * 1996-02-16 1998-04-21 Tam; Joseph Wing On Flow through nucleic acid hybridisation uses thereof and a device thereof
US6248539B1 (en) * 1997-09-05 2001-06-19 The Scripps Research Institute Porous semiconductor-based optical interferometric sensor
EP0911344B1 (en) 1997-10-15 2004-03-03 Fujirebio Inc. Anti-Apo-B-48 monoclonal antibody, hybridoma, and methods of use
AT5044U1 (de) * 2001-05-10 2002-02-25 Medsystems Diagnostics Gmbh Quantitativer einschritt immuntest in lyophilisierter form
DE60237455D1 (de) * 2001-07-12 2010-10-07 Kyowa Medex Co Ltd Verfahren zur quantifizierung von denaturiertem lipoprotein
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
WO2005038458A1 (ja) * 2003-10-15 2005-04-28 Daiichi Pure Chemicals Co., Ltd. 試料の前処理方法及びこれを利用する免疫学的測定方法
US7521248B2 (en) * 2007-04-20 2009-04-21 Atherotech, Inc. Apo B measurement system and method
EP2751575B1 (en) 2011-11-11 2018-09-12 Axis-Shield AS Blood sample assay method
CN118047854B (zh) * 2024-02-26 2024-08-02 武汉鹰达生物科技有限公司 一种人载脂蛋白a-i的分离纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2061282B (en) * 1979-10-22 1983-03-30 Symphar Sa Method for the clinical separation of a-and lipoproteins and kit for carrying out this method
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS60193926A (ja) * 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質ｂ１００抗体
JPS60253871A (ja) * 1984-05-30 1985-12-14 Nippon Koutai Kenkyusho:Kk 抗アポａ−１抗体
EP0209543A4 (en) * 1984-12-31 1989-07-11 Internat Genetic Engineering I FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins

Also Published As

Publication number Publication date
NO173902C (no) 1994-02-16
FI89214C (fi) 1993-08-25
GR3008027T3 (da) 1993-09-30
NO874056L (no) 1988-03-30
DK509287D0 (da) 1987-09-28
NO874056D0 (no) 1987-09-28
FI874253A0 (fi) 1987-09-28
IL83938A0 (en) 1988-02-29
FI874253A (fi) 1988-03-30
JP2656774B2 (ja) 1997-09-24
ATE85435T1 (de) 1993-02-15
IL83938A (en) 1991-12-15
CA1285869C (en) 1991-07-09
NZ221941A (en) 1989-05-29
PT85827B (pt) 1990-08-31
EP0262854A2 (en) 1988-04-06
JPS63277968A (ja) 1988-11-15
DE3783991T2 (de) 1993-06-09
EP0262854B1 (en) 1993-02-03
PT85827A (en) 1987-10-01
DE3783991D1 (de) 1993-03-18
NO173902B (no) 1993-11-08
AU611096B2 (en) 1991-06-06
US4828986A (en) 1989-05-09
IE60119B1 (en) 1994-06-01
AU7902887A (en) 1988-03-31
ES2053555T3 (es) 1994-08-01
IE872605L (en) 1988-03-29
EP0262854A3 (en) 1989-12-06
ZA876970B (en) 1988-03-21
DK173724B1 (da) 2001-07-30
FI89214B (fi) 1993-05-14

Similar Documents

Publication Publication Date Title
DK509287A (da) Analysemetode og diagnosesaet til undersoegelse af unormal lipidmetabolisme
NO874055L (no) Hybridomer og monoklonale paratopiske molekyler til apolipoprotein a-i.
ES2168387T3 (es) Procedimiento de fraccionamiento de soluciones que contienen sacarosa.
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
Morrison et al. The nature of the heterogeneity of prothrombin during dicoumarol therapy
ES557072A0 (es) Procedimiento para la obtencion de lineas celulares de hibridoma
Iwata et al. Membrane receptors of mouse lymphocytes for various lectins
Kinoshita et al. Simple method for analysis of apolipoproteins in high density lipoproteins by high performance liquid chromatography
Kouvonen et al. The role of sialic acid in the binding of calcium ions to intrinsic factor and its intestinal receptor
Bøg-Hansen et al. BACTERIAL LIPOPOLYSACCHARIDES INDUCE CHANGES IN LIPOPROTEIN AND ACUTE PHASE PROTEINS IN C3H/HeJ ‘NON-RESPONDER’MICE
Heller et al. FAB MASS SPECTROMETRY OF HUMAN FIBRINOGENS.
Lasne et al. Radioimmunofixation of human ferritin following serum isoelectric focusing

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired